Test Price
2,800 AED✅ Home Collection Available
APOA1 Gene Amyloidosis, Familial Visceral Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing (ISO 9001:2015 Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed genetic specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- Price: 2800 AED inclusive of genetic counselling and results delivery.
Test Overview & Methodology
The APOA1 Genetic Test screens for pathogenic variants in the apolipoprotein A-1 gene, the definitive cause of familial visceral amyloidosis. Using next-generation sequencing with 300x average read depth, it delivers unequivocal genetic confirmation for symptomatic patients and at-risk relatives. The test analyzes all coding exons and flanking intronic regions, detecting single nucleotide variants, small insertions/deletions, and copy number changes implicated in amyloid fibril deposition in the gut, liver, and kidneys.
| Feature | Our Test (UAE) | Closest Alternative |
|---|---|---|
| Precision | Full gene sequencing (all exons ±20 bp) by NGS | Targeted mutation panel only |
| Method | Illumina NovaSeq, clinically validated bioinformatics | Sanger sequencing (selected regions) |
| Turnaround | 3 to 4 weeks with genetic counselling included | 6-8 weeks, often without counselling |
Physician Insight & Safety Protocols
Dr. Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) shares: “A positive APOA1 variant does not stand alone as a diagnosis – it must be interpreted alongside kidney, liver, and gastrointestinal evaluations. Even with a negative result, if clinical suspicion remains, whole-exome sequencing may be warranted. Genetic counselling before and after testing is non-negotiable.”
Safety Advisory
Critical Pre-Test Precautions
Do not discontinue prescribed medication without consulting your doctor. Altering treatment based on genetic results without professional oversight can precipitate organ deterioration.
Exclusion Criteria & Emergency Red Flags
- Patients with active bleeding disorders or severe anaemia (phlebotomy risk).
- Neonates under 6 months – capillary FTA card preferred; physician must approve venipuncture.
- Inability to provide informed consent (mandatory for all genetic tests under UAE law).
- ER Red Flags: Sudden onset of severe abdominal pain, massive proteinuria, or acute liver failure require immediate emergency care, not elective genetic testing.
Patient FAQ & Clinical Guidance
1. What exactly does the APOA1 genetic test detect?
It detects pathogenic DNA variants in the APOA1 gene that cause hereditary visceral amyloidosis using next-generation sequencing technology. The test analyzes all coding exons and adjacent intronic splice sites, identifying single nucleotide variants, small insertions/deletions, and copy number changes known to trigger amyloid fibril deposition in the gut, liver, and kidney. A negative report reduces but does not completely eliminate the possibility of a different amyloidogenic mutation.
2. Is the home blood collection safe and DHA-approved?
All home collections follow DHA’s mobile phlebotomy standards using ISO-certified cold-chain transport and sterile single-use equipment. Our phlebotomists are MOHAP-licensed and operate between 8 AM and 11 PM, using butterfly needles for minimal discomfort. The FTA card option requires only a single drop of blood and is ideal for infants or patients with difficult veins. Samples are tracked with real-time temperature monitoring until they reach our accredited molecular lab.
3. How do I interpret the results and discuss them with a specialist?
A genetic counselor or your referring physician will review the report, explain variant significance, and recommend surveillance protocols. Results are delivered in a comprehensive PDF with technical variant classification (ACMG guidelines). A complimentary 15-minute teleconsultation with a DHA-licensed geneticist is included to clarify findings and guide family screening. If a variant of uncertain significance is reported, we advise periodic reanalysis at no additional cost for two years.
UAE Regulatory & Data Privacy Adherence
This test is fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree-Law No. 4 of 2016 on Medical Liability. Genetic information is stored in encrypted, geo-redundant servers within the UAE. Our laboratory holds ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) and is licensed under DHA Facility License 1143. All clinical procedures are reviewed by Dr. Lina Osama Zaki Quteineh (DHA 9294403).
Clinical & Logistical Metadata
| Test Name | APOA1 Gene Amyloidosis, Familial Visceral Genetic Test |
| Price (AED) | 2800 AED |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Whole Blood (EDTA) or FTA Card; VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM–11 PM |
| Methodology Used | Next-Generation Sequencing (NGS) on Illumina NovaSeq, 300x average read depth, full gene sequencing of all coding exons and flanking intronic regions |
| ICD-10-CM Code | E85.0 (Non-neuropathic heredofamilial amyloidosis) |
| LOINC Code | 21647-2 (APOA1 gene targeted mutation analysis) |
| DHA Facility License & Laboratory Address | License No. 1143; Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians